Skip to main content

Advertisement

Log in

Efficacy of the Mentha crispa in the treatment of women with Trichomonas vaginalis infection

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to evaluate the efficacy of Mentha crispa in the treatment of women with Trichomonas vaginalis infection (TVI).

Methods

This was a randomized, double-blind, and controlled clinical trial consisting of three phases, pre-treatment, treatment, and post-treatment. Sixty female patients were randomized to a treatment group, M. crispa (24 mg) or secnidazole (2,000 mg), both consisting of single dose.

Results

After treatment the proportion of patients without TVI in secnidazole group was 96.6% and in the M. crispa group was 90%, no difference was found between groups (P = 0.6120). We observed improvement in vaginal discharge, malodorous vaginal secretion, dyspareunia, dysuria, pelvic pain, and burning and itching in the genital area in patients of both groups of treatment, with no statistically significant differences between them (P > 0.05). Adverse effects were significantly higher (P = 0.0006) in the secnidazole group (66.6%) than in the M. crispa group (20%), that being mostly nausea and metallic taste with statistically significant differences between treatment groups (P < 0.001).

Conclusion

This study is the first to show that M. crispa is effective and safe, representing an alternative for the treatment of TVI in women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Domeika M, Zhurauskaya L, Savicheva A, Frigo N, Sokolovskiy E, Hallén A, Unemo M, Ballard RC (2010) Guidelines for the laboratory diagnosis of trichomoniasis in East European countries. J Eur Acad Dermatol Venereol 24:1–10

    Article  Google Scholar 

  2. Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, Hagensee ME, Farley TA, Martin DH (2009) Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis 36:11–16

    Article  PubMed  Google Scholar 

  3. Mann JR, McDermott S, Barnes TL, Hardin J, Bao H, Zhou L (2009) Trichomoniasis in pregnancy and mental retardation in children. Ann Epidemiol 19:891–899

    Article  PubMed  Google Scholar 

  4. Depuydt CE, Leuridan E, Damme PV, Bogers J, Vereecken AJ, Donders GGG (2010) Epidemiology of Trichomonas vaginalis and Human Papillomavirus infection detected by real-time PCR in flanders. Gynecol Obstet Invest 70:273–280

    Article  PubMed  Google Scholar 

  5. Hardman JG, Limbird LE, Gilman AG (2005) Goodman and Gilman’s the pharmacological basis of therapeutics. McGraw-Hill, New York

    Google Scholar 

  6. Soper D (2004) Trichomoniasis: under control or undercontrolled? Am J Obstet Gynecol 190:281–290

    Article  PubMed  Google Scholar 

  7. Gillis JC, Wiseman LR (1996) Secnidazole: a review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis. Drugs 51:621–638

    Article  PubMed  CAS  Google Scholar 

  8. Cunha GH, Fechine FV, Santos LKX, Pontes AVP, Oliveira JC, Moraes MO, Bezerra FAF, Moraes MEA (2011) Efficacy of the tincture of jalapa in the treatment of functional constipation: a double-blind, randomized, placebo-controlled study. Contemp Clin Trials 32:153–159

    Article  PubMed  Google Scholar 

  9. Terauchi M, Hiramitsu S, Akiyoshi M, Owa Y, Kato K, Obayashi S, Matsushima E, Kubota T (2011) Effects of three Kampo formulae: Tokishakuyakusan (TJ-23), Kamishoyosan (TJ-24), and Keishibukuryogan (TJ-25) on Japanese peri- and postmenopausal women with sleep disturbances. Arch Gynecol Obstet 284:913–921

    Article  PubMed  Google Scholar 

  10. Teles NSB, Fechine FV, Viana FAC, Viana IOL, Nascimento DF, Leite ALAS, Frota Bezerra FA, Moraes MO, Moraes MEA (2011) Evaluation of the therapeutic efficacy of Mentha crispa in the treatment of giardiasis. Contemp Clin Trials 32:809–813

    Article  PubMed  Google Scholar 

  11. Dimech GS, Gonçalves ES, Araújo AV, Arruda VM, Baratella-Evêncio L, Wanderley AG (2006) Evaluation of the hydroalcoholic extract of Mentha crispa on the reproductive performance in Wistar rats. Braz J Pharmacogn 16:152–157

    Google Scholar 

  12. (2010) Drugs for sexually transmitted infections. Treat Guidel Med Lett 95:53–60. http://secure.medicalletter.org/TG-article-95a. Accessed 14 June 2011

  13. Santana CF, Almeida ER, Santos ER, Souza IA (1992) Action of Mentha crispa hydroethanolic extract in patients bearing intestinal protozoan. Fitoterapia 63:409–410

    Google Scholar 

  14. Leon SR, Konda KA, Bernstein KT, Pajuelo JB, Rosasco AM, Caceres CF, Coates TJ, Klausner JD (2009) Trichomonas vaginalis infection and associated risk factors in a socially-marginalized female population in coastal Peru. Infect Dis Obstet Gynecol. doi:10.1155/2009/752437

  15. Hilber AM, Francis SC, Chersich M, Scott P, Redmond S, Bender N, Miotti P, Temmerman M, Low N (2010) Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis. PLoS ONE 5:1–11

    Article  Google Scholar 

  16. Swygard H, Seña AC, Hobbs MM, Cohen MS (2004) Trichomoniasis: clinical manifestations, diagnosis and management. Sex Transm Dis 80:91–95

    CAS  Google Scholar 

  17. Fichorova RN (2009) Impact of T. vaginalis infection on innate immune responses and reproductive outcome. J Reprod Immunol 83:185–189

    Article  PubMed  CAS  Google Scholar 

  18. Gülmezoglu AM (2007) Interventions for trichomoniasis in pregnancy (review). Cochrane Collab 4:1–9

    Google Scholar 

  19. Chersich MF, Rees HV (2008) Vulnerability of women in southern Africa to infection with HIV: biological determinants and priority health sector interventions. AIDS 22:27–40

    Article  Google Scholar 

  20. Schneider H, Coetzee DJ, Fehler HG, Bellingan A, Dangor Y, Radebe F, Ballard RC (1998) Screening for sexually transmitted diseases in rural South African women. Sex Transm Dis 74:147–152

    Google Scholar 

  21. Moodley P, Connolly C, Sturm W (2002) Interrelationships among HIV type 1 infection, bacterial vaginosis, trichomoniasis and the presence of yeasts. J Infect Dis 185:69–73

    Article  PubMed  Google Scholar 

  22. Brabin L (2001) Hormonal markers of susceptibility to sexually transmitted infections: Are we taking them seriously? BMJ 323:394–395

    Article  PubMed  CAS  Google Scholar 

  23. Baeten JM, Nyange PM, Richardson BA, Lavreys L, Chohan B, Martin HL Jr, Mandaliya K, Ndinya-Achola JO, Bwayo JJ, Kreiss JK (2001) Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study. Am J Obstet Gynecol 185:380–385

    Article  PubMed  CAS  Google Scholar 

  24. Morrison CS, Bright P, Wong EL, Kwok C, Yacobson I, Gaydos CA, Tucker HT, Blumenthal PD (2004) Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex Transm Dis 31:561–567

    Article  PubMed  Google Scholar 

  25. Mohllajee AP, Curtis KM, Martins SL, Peterson HB (2006) Hormonal contraceptive use and risk of sexually transmitted infections: a systematic review. Contraception 73:154–165

    Article  PubMed  CAS  Google Scholar 

  26. Vera EG, Orozco HH, Soto SS, Aburto EL (2008) Condom effectiveness to prevent sexually transmitted diseases. Ginecol Obstet Mex 76:88–96

    PubMed  Google Scholar 

  27. Buitrón GFR, Gonzalo BLF, Oropez RG, Romero-Cabello R (1997) Comparative study for the evaluation of the efficacy and safety of metronidazole and secnidazole in the treatment of vaginal trichomoniasis. Ginecol Obstet Mex 65:487–491

    Google Scholar 

  28. Bohbot JM, Vicaut E, Fagnen D, Brauman M (2010) Treatment of bacterial vaginosis: a multicenter, double-blind, doubly-dummy, randomized phase III study comparing secnidazole and metronidazole. Infect Dis Obstet Gynecol. doi:10.1155/2010/705692

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Elisabete A. Moraes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moraes, M.E.A., Cunha, G.H., Bezerra, M.M. et al. Efficacy of the Mentha crispa in the treatment of women with Trichomonas vaginalis infection. Arch Gynecol Obstet 286, 125–130 (2012). https://doi.org/10.1007/s00404-012-2251-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-012-2251-4

Keywords

Navigation